content_image/240193.jpg content_image/240192.jpg
Target allocations are established in consultation with outside advisors through the use of asset-liability modeling to attempt to match the duration of the plan assets with the duration of the Company’s projected benefit liability. The asset allocation strategy attempts to minimize the long-term cost of pension benefits, reduce the volatility of pension expense, and achieve a healthy funded status for the plans. 

During 2014, the 1.7 million shares of Company common stock held in plan assets were sold. Dividends paid during the year on shares held by the plan were $0.7 million. In 2013, plan assets included 1.7 million shares of common stock of the Company having a market value of $72.6 million. 

Based on the October 26, 2014 measurement date, the Company anticipates making contributions of $24.5 million to fund the pension plans during fiscal year 2015. The Company also expects to make contributions of $26.0 million during 2015 that represent benefit payments for unfunded plans. 

Benefits expected to be paid over the next ten fiscal years are as follows: 

<img src='content_image/240193.jpg'>

Post-retirement benefits are net of expected federal sub- sidy receipts related to prescription drug benefits granted under the Medicare Prescription Drug, Improvement and Modernization Act of 2003, which are estimated to be $2.3 million per year through 2024. 

The fair values of the defined benefit pension plan investments as of October 26, 2014, and October 27, 2013, by asset category and fair value hierarchy level, are as follows: 

<img src='content_image/240192.jpg'>

